Table 1.
Clinicopathological characteristics of PCa patients by BMI category
| Character | NW (n = 5) | OB/OW (n = 5) | P value |
|---|---|---|---|
| Age (years) | 65.2 ± 3.8 | 63.2 ± 2.5 | 0.67a |
| BMI (kg/m2) | 23.0 ± 0.3 | 29.0 ± 0.9 | 0.0003a |
| Gleason score | |||
| < 7 | 2 (40%) | 1 (20%) | |
| ≥ 7 | 3 (60%) | 4 (80%) | 1.00b |
| Stage | |||
| OCPCa | 2 (40%) | 2 (40%) | |
| EPCa | 3 (60%) | 3 (60%) | 1.00b |
| Smoking status | |||
| Yes | 1 | 5 | |
| No | 4 | 0 | 0.05b |
| PSA (ng/ml) | 10.7 ± 2.7 | 12.1 ± 3.23 | 0.74a |
Data are presented as mean ± SD or number (%). Significant difference between OB/OW and NW was evaluated using at test and bFisher’s exact test
OB/OW obese/overweight, NW normal weight, BMI body mass index; PSA, prostate specific antigen; PCa, prostate cancer; OCPCa, organ-confined prostate cancer; EPCa, extra-prostatic PCa